{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2004-N-0188\" sorted by posted_date descending", "rows": [["FDA-2004-N-0188-0076", "FDA", "FDA-2004-N-0188", "Reference 9 Article 11.4.15 Bovine Spongiform Encephalopathy re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:55:14Z", null, 0, 0, "0900006481ecef4e"], ["FDA-2004-N-0188-0067", "FDA", "FDA-2004-N-0188", "Reference 1 BSE - A Decade On - Part I re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:36:06Z", null, 0, 0, "0900006481ecead0"], ["FDA-2004-N-0188-0070", "FDA", "FDA-2004-N-0188", "Reference 4 Confirmed Variant Creutzfeldt-Jakob Disease (variant CJD) Case in Texas re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:42:43Z", null, 0, 0, "0900006481ecead3"], ["FDA-2004-N-0188-0091", "FDA", "FDA-2004-N-0188", "Reference 24 Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T18:58:42Z", null, 0, 0, "0900006481ecec5a"], ["FDA-2004-N-0188-0074", "FDA", "FDA-2004-N-0188", "Reference 8 Inactivation of the BSE Agent by the Heat and Pressure Process for Manufacturing Gelatine re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:51:36Z", null, 0, 0, "0900006481ecef4c"], ["FDA-2004-N-0188-0079", "FDA", "FDA-2004-N-0188", "Reference 15 Article 11.4.14 Bovine Spongiform Encephalopathy re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:04:34Z", null, 0, 0, "0900006481ecec4b"], ["FDA-2004-N-0188-0090", "FDA", "FDA-2004-N-0188", "Reference 23 BSE infectivity in jejunum, ileum and ileocaecal junction of incubating cattle re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:29:18Z", null, 0, 0, "0900006481ecec59"], ["FDA-2004-N-0188-0083", "FDA", "FDA-2004-N-0188", "Reference 16 BSE Ongoing Surveillance Plan final 71406 re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:12:50Z", null, 0, 0, "0900006481ecec4c"], ["FDA-2004-N-0188-0088", "FDA", "FDA-2004-N-0188", "Reference 21 Prevalence BSE (Bovine Spongiform Encephalopathy) re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:24:14Z", null, 0, 0, "0900006481ecec52"], ["FDA-2004-N-0188-0099", "FDA", "FDA-2004-N-0188", "Reference 28 vCJD Surveillance Data - CJD International Surveillance Network re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T19:14:05Z", null, 0, 0, "0900006481ecec5e"], ["FDA-2004-N-0188-0073", "FDA", "FDA-2004-N-0188", "Reference 7 Article 11.4.1 Bovine Spongiform Encephalopathy re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:49:11Z", null, 0, 0, "0900006481ecef4b"], ["FDA-2004-N-0188-0065", "FDA", "FDA-2004-N-0188", "Use of Materials Derived From Cattle in Human Food and Cosmetics", "Rule", "Final Rule", "2016-03-18T04:00:00Z", 2016, 3, "2016-03-18T04:00:00Z", null, "2016-03-25T16:28:15Z", "2016-06123", 0, 0, "0900006481ece21a"], ["FDA-2004-N-0188-0069", "FDA", "FDA-2004-N-0188", "Reference 3 A Novel Progressive Spongiform Encephalopathy in Cattle re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:39:21Z", null, 0, 0, "0900006481ecead2"], ["FDA-2004-N-0188-0095", "FDA", "FDA-2004-N-0188", "Reference 29 vCJD Key Facts re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T19:07:31Z", null, 0, 0, "0900006481ecec5f"], ["FDA-2004-N-0188-0097", "FDA", "FDA-2004-N-0188", "Reference 31 Report of the OIE Scientific Commission for Animal Diseases re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T19:10:58Z", null, 0, 0, "0900006481ecec61"], ["FDA-2004-N-0188-0078", "FDA", "FDA-2004-N-0188", "Reference 14 Long-Term Subclinical Carrier State Precedes Scrapie Replication and Adaptation in a Resistant Species: Analogies to Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease in Humans re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:00:27Z", null, 0, 0, "0900006481ecec4a"], ["FDA-2004-N-0188-0081", "FDA", "FDA-2004-N-0188", "Reference 12 Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:08:54Z", null, 0, 0, "0900006481ecef51"], ["FDA-2004-N-0188-0071", "FDA", "FDA-2004-N-0188", "Reference 5 Variant CJD Cases Worldwide re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:45:30Z", null, 0, 0, "0900006481ecef49"], ["FDA-2004-N-0188-0072", "FDA", "FDA-2004-N-0188", "Reference 6 Recognition of BSE Risk Status of Member Countries -D12483 re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:46:55Z", null, 0, 0, "0900006481ecef4a"], ["FDA-2004-N-0188-0092", "FDA", "FDA-2004-N-0188", "Reference 25 Scientific Opinion on BSE risk in bovine intestines and mesentery EFSA Panel on Biological Hazards (BIOHAZ) re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T19:00:32Z", null, 0, 0, "0900006481ecec5b"], ["FDA-2004-N-0188-0093", "FDA", "FDA-2004-N-0188", "Reference 26 GMIA Gelatin Handbook 2012 re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T19:02:15Z", null, 0, 0, "0900006481ecec5c"], ["FDA-2004-N-0188-0080", "FDA", "FDA-2004-N-0188", "Referemce 11 The Sourcing and Processing of Gelatin to Reduce the Potential Risk Posed by Bovine Spongiform Encephalopathy (BSE) in FDA-Regulated Products for Human Use re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:06:48Z", null, 0, 0, "0900006481ecef50"], ["FDA-2004-N-0188-0086", "FDA", "FDA-2004-N-0188", "Reference 19 BSE Summary Statistics re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:19:24Z", null, 0, 0, "0900006481ecec50"], ["FDA-2004-N-0188-0077", "FDA", "FDA-2004-N-0188", "Reference 10 Opinion of the Scientific Panel on Biological Hazards of the European Food Safety Authority on the \u201cQuantitative assessment of the human BSE risk posed by gelatine with respect to residual BSE risk\u201d re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:57:28Z", null, 0, 0, "0900006481ecef4f"], ["FDA-2004-N-0188-0068", "FDA", "FDA-2004-N-0188", "Reference 2 Transmission Dynamics and Epidemiology of BSE in British Cattle re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:37:46Z", null, 0, 0, "0900006481ecead1"], ["FDA-2004-N-0188-0085", "FDA", "FDA-2004-N-0188", "Reference 18 BSE - An Appraisal of the Current Epidemic in the United Kingdom re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-25T16:40:09Z", null, 0, 0, "0900006481ecec4f"], ["FDA-2004-N-0188-0087", "FDA", "FDA-2004-N-0188", "Reference 20 Scientific Opinion on BSE Risk in Bovine Intestines EFSA Panel on Biological Hazards (BIOHAZ) re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:21:41Z", null, 0, 0, "0900006481ecec51"], ["FDA-2004-N-0188-0096", "FDA", "FDA-2004-N-0188", "Reference 30 WHO Tables On Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T19:09:39Z", null, 0, 0, "0900006481ecec60"], ["FDA-2004-N-0188-0066", "FDA", "FDA-2004-N-0188", "List of References - 2011-902 re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-25T16:33:27Z", null, 0, 0, "0900006481eceacf"], ["FDA-2004-N-0188-0084", "FDA", "FDA-2004-N-0188", "Reference 17 EC, The TSE Roadmap re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:15:04Z", null, 0, 0, "0900006481ecec4d"], ["FDA-2004-N-0188-0089", "FDA", "FDA-2004-N-0188", "Reference 22 REPORT ON MEASURES RELATING TO BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) IN THE UNITED STATES re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:27:17Z", null, 0, 0, "0900006481ecec53"], ["FDA-2004-N-0188-0098", "FDA", "FDA-2004-N-0188", "Reference 32 Prevalent Abnomal Prior Protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T19:12:26Z", null, 0, 0, "0900006481ecec62"], ["FDA-2004-N-0188-0082", "FDA", "FDA-2004-N-0188", "Reference 13 Transmission of the BSE Agent to Mice in the Absence of Detectable Abnormal Prion Protein re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T17:10:46Z", null, 0, 0, "0900006481ecef52"], ["FDA-2004-N-0188-0075", "FDA", "FDA-2004-N-0188", "Reference 8B Inactivation of the bovine-spongiform-encephalopathy (BSE) agent by the acid and alkaline processes used in the manufacture of bone gelatine re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T16:53:55Z", null, 0, 0, "0900006481ecef4d"], ["FDA-2004-N-0188-0094", "FDA", "FDA-2004-N-0188", "Reference 27 An Evaluation of the Risk of Variant Creutzfeldt-Jakob Disease from Exposure to Cattle-Derived Protein Used in Cosmetics re Use of Materials Derived From Cattle in Human Food and Cosmetics", "Supporting & Related Material", "Background Material", "2016-03-18T04:00:00Z", 2016, 3, null, null, "2016-03-18T19:04:22Z", null, 0, 0, "0900006481ecec5d"], ["FDA-2004-N-0188-0051", "FDA", "FDA-2004-N-0188", "Use of Materials Derived from Cattle in Human Food and Cosmetics", "Rule", "Interim Final Rule", "2013-03-04T05:00:00Z", 2013, 3, "2013-03-04T05:00:00Z", "2013-05-04T03:59:59Z", "2014-01-14T13:01:49Z", "2013-04869", 0, 0, "090000648121690e"], ["FDA-2004-N-0188-0050", "FDA", "FDA-2004-N-0188", "FDA/Regulations Policy and Management Staff (RPMS) to the Division of Dockets Management - E.O. 12866 Review - [Use of Materials Derived From Cattle in Human Food and Cosmetics - Interim Final Rules and Request for Comments ] - Reference 2 [See FDA-2004-N-0188-0023]", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2009-10-27T04:00:00Z", 2009, 10, null, null, "2009-10-27T14:40:11Z", null, 0, 0, "0900006480a4c757"], ["FDA-2004-N-0188-0046", "FDA", "FDA-2004-N-0188", "Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Request for Designation as Country Not Subject to the Restrictions Applicable to Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing, Material From Cattle", "Notice", "NAL-Notice of Approval", "2008-07-01T04:00:00Z", 2008, 7, "2008-07-01T04:00:00Z", null, "2008-07-01T13:05:21Z", "E8-14882", 0, 0, "090000648064e12b"], ["FDA-2004-N-0188-0035", "FDA", "FDA-2004-N-0188", "Use of Materials Deriverd From Cattle Human Food and Cosmetic - References List - Background Material", "Supporting & Related Material", "BKG-Background Material", "2008-04-17T04:00:00Z", 2008, 4, null, null, "2008-04-18T01:10:44Z", null, 0, 0, "090000648050c4f7"], ["FDA-2004-N-0188-0034", "FDA", "FDA-2004-N-0188", "Use of Materials Derived From Cattle in Human Food and Cosmetics - Interim Final Rule and Request for Comments", "Rule", "NIR-Notice of Interim Rule", "2008-04-17T04:00:00Z", 2008, 4, "2008-04-17T04:00:00Z", "2008-07-17T03:59:59Z", "2011-06-11T16:25:55Z", "08-01142", 0, 0, "090000648050c23c"], ["FDA-2004-N-0188-0031", "FDA", "FDA-2004-N-0188", "See FDA-2004-N-0188-0050", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2005-11-10T05:00:00Z", 2005, 11, null, null, "2009-10-27T14:42:03Z", null, 0, 0, "09000064804708d9"], ["FDA-2004-N-0188-0032", "FDA", "FDA-2004-N-0188", "See FDA-2004-N-0188-0050", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2005-11-10T05:00:00Z", 2005, 11, null, null, "2009-10-27T14:42:29Z", null, 0, 0, "09000064804708da"], ["FDA-2004-N-0188-0033", "FDA", "FDA-2004-N-0188", "See FDA-2004-N-0188-0050", "Supporting & Related Material", "REF-Reference (internal unless indicated)", "2005-11-10T05:00:00Z", 2005, 11, null, null, "2009-10-27T14:42:40Z", null, 0, 0, "09000064804708db"], ["FDA-2004-N-0188-0023", "FDA", "FDA-2004-N-0188", "Use of Materials Derived From Cattle in Human Food and Cosmetics - Interim Final Rule and Request for Comments", "Rule", "NFR-Notice of Final Rule", "2005-09-07T04:00:00Z", 2005, 9, "2005-09-06T04:00:00Z", "2005-11-08T04:59:59Z", "2009-07-30T19:47:44Z", null, 0, 0, "09000064804708c1"], ["FDA-2004-N-0188-0004", "FDA", "FDA-2004-N-0188", "BSE Stakeholders Conference Calls", "Other", "SUP-Supplement", "2004-07-30T04:00:00Z", 2004, 7, null, null, "2008-04-18T03:54:29Z", null, 0, 0, "09000064804702ff"], ["FDA-2004-N-0188-0002", "FDA", "FDA-2004-N-0188", "Environmental Assessment", "Supporting & Related Material", "EA-Environmental Assessment", "2004-07-15T04:00:00Z", 2004, 7, null, null, "2008-04-12T00:39:35Z", null, 0, 0, "09000064804702f7"], ["FDA-2004-N-0188-0001", "FDA", "FDA-2004-N-0188", "Use of Materials Derived From Cattle in Human Food and Cosmeticsm - Notice of Interim Final Rule", "Notice", "NIR-Notice of Interim Rule", "2004-07-15T04:00:00Z", 2004, 7, "2004-07-14T04:00:00Z", "2004-10-13T03:59:59Z", "2009-07-30T19:46:16Z", null, 0, 0, "09000064804702a6"], ["FDA-2004-N-0188-0003", "FDA", "FDA-2004-N-0188", "Finding of No Significant Impact", "Supporting & Related Material", "FONS-Finding of no Significant Impact", "2004-07-15T04:00:00Z", 2004, 7, null, null, "2008-04-12T00:39:35Z", null, 0, 0, "09000064804702f8"]], "truncated": false, "filtered_table_rows_count": 48, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2004-N-0188"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188", "results": [{"value": "FDA", "label": "FDA", "count": 48, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2004-N-0188", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 41, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Rule", "label": "Rule", "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&document_type=Rule", "selected": false}, {"value": "Notice", "label": "Notice", "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188", "results": [{"value": 2016, "label": 2016, "count": 35, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&posted_year=2016", "selected": false}, {"value": 2004, "label": 2004, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&posted_year=2004", "selected": false}, {"value": 2005, "label": 2005, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&posted_year=2005", "selected": false}, {"value": 2008, "label": 2008, "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&posted_year=2008", "selected": false}, {"value": 2009, "label": 2009, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&posted_year=2009", "selected": false}, {"value": 2013, "label": 2013, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&posted_year=2013", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2004-N-0188&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 45.514164958149195, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}